NTC grants further license and distribution rights to Santen for its fixed combination dexamethasone with levofloxacin in South East Asia

  • May 22, 2019

Milan, Italy, May 22, 2019 – NTC Srl, R&D driven pharmaceutical company with headquarters in Italy, and Santen Pharmaceutical Co. Ltd, a global leader in ophthalmology, announce today the extension of their original agreement for Europe signed in December 2017.

NTC closes a deal with Bruno Farmaceutici for the development of a new solution to treat external and medium otitis with tympanostomy in children.

  • Feb 26, 2019

Milan, February 26th 2019 – NTC Srl, an Italian pharmaceutical company with significant expertise in research and development in ophthalmology, announces today a commercial partnership with Bruno Farmaceutici S.p.A.

NTC Pharma España moves the first steps in the world of Ophthalmology in Spain

  • Feb 03, 2019

During FacoElche Congress (31st January – 2nd February 2019), NTC Ophthalmics Ibérica organized its first Symposium focused on the rational use of topical antibiotics in ophthalmology.

Beyond CPhI: NTC is running talks and negotiations with the aim to reinforce and expand its reach internationally

  • Nov 27, 2018

One month passed since last CPhI in Madrid. There, NTC team met more than 200 potential customers and suppliers coming from 50 countries all over the world.

We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it. READ MORE